Biogen stock is getting favorable ratings after successful trial results for its latest Alzheimer's treatment Lecanemab is Biogen's latest attempt to cure the disease after its...
Converting mutual funds to ETFs is an emerging trend ETFs offer flexible trading and more transparency 2 JP Morgan ETFs worth a look The conversion of mutual funds into...
Inflation worries continue to weigh on equity markets Earnings season will likely increase volatility ETFs offer investors ability to diversify Earnings season has started with...
Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US...
Concerns over high inflation levels and the war in Ukraine have meant increased volatility for stocks on Wall Street and other exchanges around the world. For instance, the DAX...
A slew of macroeconomic difficulties washed over Wall Street in the first two months of 2022, leading to heightened market volatility. So, investors have been paying close...
Bearish stock predictions amid geopolitical and economic concerns are unnerving market participants. Yet, seasoned investors realize that having a diversified portfolio and...
Wednesday, January 19, 2022The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks,...
AbbVie ABBV announced that the FDA has granted a Breakthrough Therapy Designation (BTD) to its investigational antibody-drug conjugate (ADC) telisotuzumab vedotin (Teliso-V) for...
Small biotech Aprea Therapeutics (NASDAQ:APRE), Inc. APRE announced that the FDA has removed the full clinical hold on a study evaluating its lead product candidate, eprenetapopt...
it will go up: the chart formed an "bulllish doji star"
1
This Is one and only real competitor in covid test from POLAND
http://scopefluidics.com/scope-fluidics-is-developing-an-ultra-fast-covid-19-panel-for-its-pcrone-rapid-molecular-diagnostic-system/
0
Roche just announced as the test pushed through for Covid 19 Tessting. Up Up Up!
2
Jan 26, 2020 Sun $41.20 its GENE is dazzling as always focusing on breakthrough sciences